Challenges in the small-scale preparation of radiopharmaceuticals - A European perspective

Fabad Journal of Pharmaceutical Sciences

Volumn 32, Issue 3, 2007, Pages 131-138

  Decristoforo, Clemens ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Radiopharmacy Committee of the European Association of Nuclear Medicine   (Austria)

Author keywords

European regulations; PET; Radiopharmaceuticals; Small scale preparation; SPECT

Indexed keywords

EID: 77952896068     PISSN: 13004182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Directive 2001/83/EC of the European Parliament and the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Official Journal L 311, 28.11.2001, p. 6.
2. Verordnung über radioaktive oder mit ionisierenden Strahlen behandelte Arzneimittel (AmRadV). BGBl. I S. 48.
3. Decreto legislativo 6 novembre 2007, N 200, Supplemento ordinario alla Gazetta Ufficiale, Seria Generale.26:72, 2007.
4. Directive 2001/83/EC of the European Parliament and the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Official Journal L 311: 6, 28.11.2001.
5. EudraLex. The Rules Governing Medicinal Products in the European Union. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/eudralex-en.htm
6. PIC/S Guide to good practices for preparation of medicinal products in healthcare establishments. Pharmaceutical Inspection Convention Pharmaceutical Inspection Co-operation Scheme, Pe 010-11
7. Guidelines on Current Good Radiopharmacy Practice (cGRPP) in the Preparation of Radiopharmaceuticals. http://www.eanm.org/scientific-info/ guidelines/gl-radioph- cgrpp.pdf
8. European Pharmacopoeia, 6th edition. European directorate for the quality of medicines (EDQM), Strasbourg, 2008.
9. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal L. 121, 1.5.2001, p. 34-44.
10. Guideline on the requirements of the chemical and pharmaceutical quality documentation concerning investigational medicinal products in clinical trials CHMP/QWP/185401/2004.
11. Commission Directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use. Official Journal L. 262, 14.10.2003, p. 22-26.
12. Commission Directive 2005/28/EC of 8 April 2005 laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products. Official Journal L. 91, 9.4.2005, p. 13-19.
13. Guideline on strategies to identify and mitigate risks for first-inhuman clinical trials with Investigational Medicinal Products. CHMP/SWP/28367/07.
14. Final Position Paper on non-clinical safety studies to support clinical trials with a single microdose EMEA/CPMP/SWP/2599/02/Rev1.
15. Verbruggen A, Coenen HH, Deverre JR, Guilloteau D, Langstrom B, Salvadori PA, Halldin C. Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU. Eur J Nucl Med Mol Imaging 35: 2144-2151, 2008.
16. Radiopharmacy Committee of the EANM https://www.eanm.org/committees/ radiopharmacy/rapha-education.php?navId=135
17. Bogsrud TV, Herold TJ, Mahoney DW, Hung JC. Comparison of three cold kit reconstitution techniques for the reduction of hand radiation dose. Nucl Med Commun. 20: 761-767, 1999.
18. Lee CC, Sui G, Elizarov A, Shu CJ, Shin YS, Dooley AN, Huang J, Daridon A, Wyatt P, Stout D, Kolb HC, Witte ON, Satyamurthy N, Heath JR, Phelps ME, Quake SR, Tseng HR. Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics. Science. 310(5755): 1793-1796, 2005. (Pubitemid 41814377)